Cannabis extract eases muscle stiffness typical of multiple sclerosis
Cannabis seems to ease the painful muscle stiffness typical of multiple sclerosis, indicate phase III trial results, published in the Journal of Neurology Neurosurgery and Psychiatry.
Neuroscience
Oct 09, 2012 |
5 / 5 (2) |
0
|
Cancer drug improves survival in patients with metastatic melanoma
(Medical Xpress)—Results of a University of Arizona Cancer Center's scientist-led clinical trial show that a drug already approved for breast and lung cancer improved progression-free survival in patients ...
Cancer
Nov 14, 2012 |
5 / 5 (2) |
0
|
Combination therapy may enhance gemcitabine activity
Oncologists who treat patients with pancreatic cancer may be one step closer to understanding why gemcitabine, the only currently available treatment, works in some cases but not in others, according to a paper in Cancer Di ...
Cancer
Feb 28, 2012 |
3 / 5 (2) |
0
New drug extends survival in patients with drug-resistant prostate cancer
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression ...
Cancer
Feb 01, 2012 |
5 / 5 (1) |
0
|
Many lung cancer patients get radiation therapy that may not prolong their lives
A new study has found that many older lung cancer patients get treatments that may not help them live longer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that p ...
Cancer
Feb 13, 2012 |
5 / 5 (1) |
0
Japan's DSP to buy US cancer start-up for $2.6 bn
Japanese drugs giant Dainippon Sumitomo Pharma will buy US biotechnology cancer specialist Boston Biomedical for a price that could hit $2.6 billion, the companies announced Thursday.
Cancer
Mar 01, 2012 |
5 / 5 (1) |
0
Harmless human virus may be able to boost the effects of chemotherapy
A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published in Clinical Cancer Research.
Cancer
Apr 03, 2012 |
5 / 5 (1) |
0
Enzalutamide adds five months survival in late-stage prostate cancer
Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer ...
Cancer
Aug 16, 2012 |
5 / 5 (1) |
0
New MS drug proves effective where others have failed
A drug which 'reboots' a person's immune system has been shown to be an effective treatment for multiple sclerosis (MS) patients who have already failed to respond to the first drug with which they were treated (a 'first-line' ...
Neuroscience
Oct 31, 2012 |
5 / 5 (1) |
0
Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients
Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients ...
Cancer
Sep 23, 2011 |
4 / 5 (1) |
0
Bone-strengthening drug gives pain relief in prostate cancer bone metastases
Stockholm, Sweden: Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has ...
Cancer
Sep 25, 2011 |
4 / 5 (1) |
0
Rejected Alzheimer's drug shows new potential
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped ...
Psychology & Psychiatry
Jul 31, 2012 |
4 / 5 (1) |
1
|
Adjuvant radiochemotherapy has lasting benefit in gastric cancer
(HealthDay) -- Ten-year data from the Southwestern Oncology Group-directed Intergroup Study 0116 confirm the benefits of adjuvant radiochemotherapy after gastric cancer resection in terms of overall survival ...
Cancer
May 18, 2012 |
1 / 5 (1) |
0
Many psoriasis patients undertreated for CV risk factors
(HealthDay) -- A large proportion of patients with moderate-to-severe plaque psoriasis are underdiagnosed and undertreated for cardiovascular (CV) risk factors, according to a study published in the July issue ...
Diseases, Conditions, Syndromes
Jun 22, 2012 |
1 / 5 (1) |
0
Golden age of prostate cancer treatment hailed as fourth drug in two years extends life
The head of one of the UK's leading cancer research organisations has hailed a golden age in prostate cancer drug discovery as for the fourth time in two years results are published finding a new drug can significantly extend ...
Cancer
Aug 15, 2012 |
1 / 5 (1) |
1
|
